Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.
| Publicado en: | Targeted Oncology pp. 1 - 5 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Sep2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=197109755&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 197109755 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: Sep2026 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 197109755 10.1007/s11523-026-01245-w 197109755 ppf: 1 ppct: 4 formats: tig: atl: Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer. aug: au: Dieras, Veronique Curigliano, Giuseppe Martin, Miguel Lerebours, Florence Tsurutani, Junji Savard, Marie-France Jerzak, Katarzyna J. Hu, Xichun O’Sullivan, Ciara C. Tokunaga, Eriko Okines, Alicia Huang, Chiun-Sheng Jacot, William Sohn, Joohyuk Cronemberger Silva, Eduardo Mueller, Volkmar Yang, Shan Granata, Giovanna Shen, Qi Hamilton, Erika affil: Medical Oncology Department, Centre Eugène Marquis sug: pubtype: Academic Journal doctype: Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|